Fundz

NS Pharma, Inc. Appoints Yukiteru Sugiyama as President at Its US Headquarters

PRIVATEJul 10, 2024

Position

President

Company

NS Pharma

Yukiteru Sugiyama
y.sugiyama@nspharma.com
ParamusBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Yukiteru Sugiyama, Ph.D., has been appointed as the new President of NS Pharma, Inc. at its US headquarters, replacing retiring president Tsugio Tanaka, MSc as of June 30, 2024. Sugiyama brings with him extensive experience in research, clinical development, and commercial functions, with a focus on empathy for patients and transparency between stakeholders.

Quick answer

NS Pharma, Inc. Appoints Yukiteru Sugiyama as President at Its US Headquarters (July 10, 2024). NS Pharma is based in Paramus, New Jersey, United States.

Who is the new President at NS Pharma?
NS Pharma named Yukiteru Sugiyama President, announced July 10, 2024.
What did NS Pharma announce on July 10, 2024?
Yukiteru Sugiyama, Ph.D., has been appointed as the new President of NS Pharma, Inc. at its US headquarters, replacing retiring president Tsugio Tanaka, MSc as of June 30, 2024. Sugiyama brings with him extensive experience in research, clinical development, and commercial functions, with a focus on empathy for patients and transparency between stakeholders.
What does NS Pharma do?
NS Pharma, Inc., is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. NS Pharma is a registered trademark of the Nippon Shinyaku group of companies.
Where is NS Pharma based?
NS Pharma is based in Paramus, New Jersey, United States.
Which similar companies made leadership changes around the same time?
AbbVie Inc. (July 10, 2024), Jazz Pharmaceuticals plc (July 9, 2024), Pfizer (July 9, 2024) and CASI Pharmaceuticals (July 8, 2024) also announced leadership changes within 45 days of NS Pharma.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at NS Pharma, and when

A new leader at NS Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day NS Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NS Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NS Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NS Pharma

Location

Paramus, New Jersey, United States

About

NS Pharma, Inc., is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. NS Pharma is a registered trademark of the Nippon Shinyaku group of companies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NS Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Yukiteru
Likely contact at this company
••••••••@••••••••

See Yukiteru's verified email →

Donald
Likely contact at this company
••••••••@••••••••

See Donald's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NS Pharma's next move

Learn about Strategic plan

NS Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.